Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by guerreiroon Sep 04, 2010 4:55pm

319 Views

Post# 17415684

We have a WINNER

It takes time to rollback, next options for the insiders and only after you will see some activity in HLO.
HLO is selling at a big discount to its net assets.
If you want to gather honey, don"t kick over the beehieve. Its all about fundamentals, will will have soon a robust day!!!. but it sometimes takes time.

<< Previous

Bullboard Posts

Next >>

Immigration technology stock CanPR begins trading on the TSXV